CRH shares rose 4.7% after the company raised its full-year Adjusted EBITDA outlook to $7.8–$8.0 billion and pointed to positive 2027 trends. The update came despite flat year-over-year Q3 Adjusted EBITDA and an 80-basis-point margin decline.
CRH achieved a record third quarter in 2025, raising its adjusted EBITDA guidance for the year, driven by strong market demand, strategic acquisitions, and operational efficiency.